'Other' targets in lung cancer
25 Jul 2016
'Other' targets in lung cancer
Developments in gastrointestinal tumour treatment
Editor's Choice for July 2016
Towards deciphering the functional genetics and neo-antigenic landscape in melanoma
Polycomb repressors and epigenetic therapy
DNA repair and mutations as targets for personalised therapy
The changing process of drug discovery and design
Obesity promotes pancreatic cancer progression and resistance
Connections in cancer-host immune signalling
ERß expression predicts breast cancer risk in hyperplasia
Advances in early detection
Regulation of T cells in tissues and tumours